Abstract
Studies were made on the effects of stilbene derivatives isolated from medicinal plants on arachidonate metabolism and degranulation in human polymorphonuclear leukocytes (PMN-L). Resveratrol (3,4',5-trihydroxystilbene) isolated from the roots of Reynoutria japonica was found to inhibit the 5-lipoxygenase products 5-hydroxy-6,8,11,14-eicosatetraenoic acid (5-HETE), 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid (5,12-diHETE) and leukotriene C4(LTC4); its concentrations for 50% inhibition (IC50) were 8.90 x 10(-6) M, 6.70 x 10(-6) M and 1.37 x 10(-6) M, respectively. The IC50 of 5-HETE, 5,12-diHETE and LTC4 formations of synthetic 3,3',4-trihydroxystilbene were 5.90 x 10(-6) M, 6.30 x 10(-7) M and 8.80 x 10(-7) M, respectively. Moreover, they inhibited the release of lysosomal enzyme such as lysozyme and beta-glucuronidase induced by calcium ionophore A 23187 from human PMN-L at 10(-3)-10(-4) M.
MeSH terms
-
Arachidonic Acid / metabolism*
-
Autoradiography
-
Calcimycin / pharmacology
-
Cell Degranulation / drug effects*
-
Cyclic AMP / metabolism
-
Fatty Acids, Unsaturated / metabolism
-
Glucuronidase / metabolism
-
Humans
-
Hydroxyeicosatetraenoic Acids / antagonists & inhibitors
-
Hydroxyeicosatetraenoic Acids / metabolism
-
Leukotriene B4 / antagonists & inhibitors
-
Leukotriene B4 / metabolism
-
Leukotriene C4 / antagonists & inhibitors
-
Leukotriene C4 / metabolism
-
Lysosomes / drug effects
-
Lysosomes / enzymology
-
Muramidase / metabolism
-
Neutrophils / drug effects*
-
Plant Roots / chemistry
-
Plants, Medicinal / chemistry*
-
Resveratrol
-
Stilbenes / isolation & purification
-
Stilbenes / pharmacology*
-
Structure-Activity Relationship
Substances
-
Fatty Acids, Unsaturated
-
Hydroxyeicosatetraenoic Acids
-
Stilbenes
-
Leukotriene B4
-
Arachidonic Acid
-
Leukotriene C4
-
Calcimycin
-
5-hydroxy-6,8,11,14-eicosatetraenoic acid
-
12-hydroxy-5,8,10-heptadecatrienoic acid
-
3,3',4-trihydroxystilbene
-
15-hydroxy-5,8,11,13-eicosatetraenoic acid
-
Cyclic AMP
-
Muramidase
-
Glucuronidase
-
Resveratrol